Literature DB >> 2744861

Pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae, does not require a thiol group for in vitro activity.

F K Saunders1, T J Mitchell, J A Walker, P W Andrew, G J Boulnois.   

Abstract

The role of the single cysteine residue in the activity of the thiol-activated toxin pneumolysin was investigated using oligonucleotide-mediated, site-directed mutagenesis. Three modified toxins in which the cysteine residue was changed to an alanine, a serine, or a glycine residue were purified to homogeneity and examined for activity. The Cys-428----Ala modified toxin was indistinguishable from the wild-type recombinant toxin in terms of hemolytic activity and lytic and inhibitory effects on human polymorphonuclear leukocytes (PMN), indicating that the cysteine residue is not essential for toxin activity. The Cys-428----Ser and Cys-429----Gly modified toxins had reduced activity on erythrocytes and polymorphonuclear leukocytes, being 6 and 20 times less active than the wild type, respectively. However, all the modified toxins formed oligomers in erythrocyte membranes to the same extent as the wild-type recombinant toxin. This suggests that the cysteine residue at position 428 is involved in neither the binding of toxin to membranes nor its insertion into the membrane, and also that the formation of oligomers is not by itself sufficient for toxin activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744861      PMCID: PMC313484          DOI: 10.1128/iai.57.8.2547-2552.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity.

Authors:  M Pinkney; E Beachey; M Kehoe
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Purification of pneumolysin.

Authors:  C N Shumway; S J Klebanoff
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

4.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Morphologic changes in the membranes of red blood cells undergoing hemolysis.

Authors:  R R Dourmashkin; W F Rosse
Journal:  Am J Med       Date:  1966-11       Impact factor: 4.965

7.  Interaction of alveolysin A sulfhydryl-activated bacterial cytolytic toxin with thiol group reagents and cholesterol.

Authors:  C Geoffroy; J E Alouf
Journal:  Toxicon       Date:  1982       Impact factor: 3.033

8.  Binding of cholesterol by sulfhydryl-activated cytolysins.

Authors:  M K Johnson; C Geoffroy; J E Alouf
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Hydrogen peroxide and superoxide release by alveolar macrophages from normal and BCG-vaccinated guinea-pigs after intravenous challenge with Mycobacterium tuberculosis.

Authors:  P S Jackett; P W Andrew; V R Aber; D B Lowrie
Journal:  Br J Exp Pathol       Date:  1981-08
View more
  39 in total

1.  Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils.

Authors:  R Cockeran; H C Steel; T J Mitchell; C Feldman; R Anderson
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Dissociated linkage of cytokine-inducing activity and cytotoxicity to different domains of listeriolysin O from Listeria monocytogenes.

Authors:  Chikara Kohda; Ikuo Kawamura; Hisashi Baba; Takamasa Nomura; Yutaka Ito; Terumi Kimoto; Isao Watanabe; Masao Mitsuyama
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

3.  Differential sensitivity of pneumolysin-induced channels to gating by divalent cations.

Authors:  Y E Korchev; C L Bashford; C A Pasternak
Journal:  J Membr Biol       Date:  1992-05       Impact factor: 1.843

4.  Alveolysin, the thiol-activated toxin of Bacillus alvei, is homologous to listeriolysin O, perfringolysin O, pneumolysin, and streptolysin O and contains a single cysteine.

Authors:  C Geoffroy; J Mengaud; J E Alouf; P Cossart
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

5.  The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity.

Authors:  M Pinkney; E Beachey; M Kehoe
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

Review 6.  Listeria pathogenesis and molecular virulence determinants.

Authors:  J A Vázquez-Boland; M Kuhn; P Berche; T Chakraborty; G Domínguez-Bernal; W Goebel; B González-Zorn; J Wehland; J Kreft
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

7.  Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations in the pneumolysin gene.

Authors:  A M Berry; A D Ogunniyi; D C Miller; J C Paton
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

8.  The Arcanobacterium (Actinomyces) pyogenes hemolysin, pyolysin, is a novel member of the thiol-activated cytolysin family.

Authors:  S J Billington; B H Jost; W A Cuevas; K R Bright; J G Songer
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

9.  Pneumolysin Mediates Platelet Activation In Vitro.

Authors:  Jan Gert Nel; Chrisna Durandt; Timothy J Mitchell; Charles Feldman; Ronald Anderson; Gregory R Tintinger
Journal:  Lung       Date:  2016-05-18       Impact factor: 2.584

10.  Streptococcus pneumoniae-induced caspase 6-dependent apoptosis in lung epithelium.

Authors:  Bernd Schmeck; Ralph Gross; Phillipe Dje N'Guessan; Andreas C Hocke; Sven Hammerschmidt; Tim J Mitchell; Simone Rosseau; Norbert Suttorp; Stefan Hippenstiel
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.